None
EN
Centre says 120 adverse events reported after nearly 56 lakh HPV vaccine doses administered, HC refuses to stay drive
['Sohini Ghosh', 'Sohini Ghosh Is A Senior Correspondent At The Indian Express. Previously Based In Ahmedabad Covering Gujarat', 'She Recently Moved To The New Delhi Bureau', 'Where She Primarily Covers Legal Developments At The Delhi High Court', 'Professional Profile', 'Background', 'An Alumna Of The Asian College Of Journalism', 'Acj', 'She Previously Worked With Et Now Before Joining The Indian Express.', 'Core Beats']
The Indian Express
The court, which was hearing a PIL that flagged concerns over safety of administering Merck’s HPV vaccine Gardasil, noted that there was “no instant harm”.
Out of the 120 AEFI cases, 42 were classified as “serious/severe”, but no deaths were reported, the Centre mentioned.
Of the 42 AEFI cases, causality assessment has been completed in 20 cases, it said, adding that none of the AEFI cases required hospitalisation beyond a maximum of two days.
A 2017 report by the Global Advisory Committee on vaccine safety that broadly held the vaccine to be safe, had observed, “Despite the extensive safety data available for this vaccine, attention has continued to focus on spurious case reports and unsubstantiated allegations.”
Recording the petitioners’ apprehensions raised on adverse events, efficacy and the government’s justification of administering HPV vaccination in campaign mode, the court directed the Centre to file an affidavit in response to the PIL.